United States Pharmaceuticals

Corium International Inc (CORI)

Track

Ticker: CORI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 27 Nov 2018
Value US$3,570,803.76 | Price 167.69 | Shares 75,154 (-20.0%)
Buy 27 Nov 2018
Value US$1,212,741.17 | Price 93.11 | Shares 43,181 (-10.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
75,154 -20.0%
167.69
US$3,570,804 		75,154 -20.0% 167.69 US$3,570,804
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
43,181 -10.4%
93.11
US$1,212,741 		43,181 -10.4% 93.11 US$1,212,741
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
22,220 -2.9%
427.78
US$3,322,340 		22,220 -2.9% 427.78 US$3,322,340
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -9.0%
12.51
US$6,255,000 		500,000 -9.0% 12.51 US$6,255,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -8.2%
12.50
US$6,250,000 		500,000 -8.2% 12.50 US$6,250,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
282,447 -4.4%
12.51
US$3,533,412 		282,447 -4.4% 12.51 US$3,533,412
2018-08-17 2018-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer

Officer
346 -1.0%
9.01
US$3,117 		346 -1.0% 9.01 US$3,117
2018-08-17 2018-08-17 S Sale Singh Parminder

CTO & Vice President, R&D

Officer
3,133 -16.5%
9.01
US$28,224 		3,133 -16.5% 9.01 US$28,224
2018-08-17 2018-08-17 S Sale BREUIL ROBERT S

Chief Financial Officer

Officer
972 -6.3%
9.01
US$8,756 		972 -6.3% 9.01 US$8,756
2018-08-17 2018-08-17 S Sale Sarret Joseph J.

Chief Business Officer

Officer
3,565 -18.0%
9.01
US$32,116 		3,565 -18.0% 9.01 US$32,116
2018-08-17 2018-08-17 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
34,320 -12.2%
8.96
US$307,586 		34,320 -12.2% 8.96 US$307,586
2018-08-17 2018-08-17 S Sale STAPLE PETER D

President & CEO

Executive Director
2,701 -0.9%
9.01
US$24,332 		2,701 -0.9% 9.01 US$24,332
2018-08-17 2018-08-16 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
39,320 -12.4%
8.66
US$340,606 		39,320 -12.4% 8.66 US$340,606
2018-08-17 2018-08-15 PlS Planned sale Thomas Robert Non-Executive Director
35,608 -100.0%
8.86
US$315,476 		35,608 -100.0% 8.86 US$315,476
2018-01-18 2018-01-18 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
310,000 +5.1%
12.80
US$3,968,000 		310,000 +5.1% 12.80 US$3,968,000
2018-01-18 2018-01-17 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
149,650 +2.5%
12.24
US$1,831,716 		149,650 +2.5% 12.24 US$1,831,716
2018-01-18 2018-01-16 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
50,350 +0.9%
11.83
US$595,640 		50,350 +0.9% 11.83 US$595,640
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.95
US$273,750 		25,000 -0.7% 10.95 US$273,750
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
9,255 -0.3%
10.96
US$101,435 		9,255 -0.3% 10.96 US$101,435
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -2.7%
10.95
US$1,095,000 		100,000 -2.7% 10.95 US$1,095,000
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
65,345 -1.7%
11.01
US$719,448 		65,345 -1.7% 11.01 US$719,448
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
10.97
US$4,388 		400 -0.0% 10.97 US$4,388
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.88
US$272,000 		25,000 -0.7% 10.88 US$272,000
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.85
US$271,250 		25,000 -0.7% 10.85 US$271,250
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
250,000 -6.1%
10.97
US$2,742,500 		250,000 -6.1% 10.97 US$2,742,500
2017-11-03 2017-11-02 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
150,000 -3.6%
11.05
US$1,657,500 		150,000 -3.6% 11.05 US$1,657,500
2017-10-06 2017-10-04 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
218,100 -4.9%
11.01
US$2,401,107 		218,100 -4.9% 11.01 US$2,401,107
2017-08-23 2017-08-22 S Sale Singh Parminder

CTO & Vice President, R&D
22,822 -74.2%
7.61
US$173,561 		22,822 -74.2% 7.61 US$173,561
2017-08-23 2017-08-21 S Sale Singh Parminder

CTO & Vice President, R&D
7,593 -19.8%
7.53
US$57,139 		7,593 -19.8% 7.53 US$57,139
2017-08-18 2017-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer
12,012 -27.1%
7.62
US$91,529 		12,012 -27.1% 7.62 US$91,529
2017-08-18 2017-08-17 S Sale Singh Parminder

CTO & Vice President, R&D
32,000 -45.5%
7.61
US$243,619 		32,000 -45.5% 7.61 US$243,619
2017-08-18 2017-08-16 S Sale Sweemer Timothy D

Chief Accounting Officer
15,488 -25.9%
7.82
US$121,156 		15,488 -25.9% 7.82 US$121,156
2017-07-21 2017-07-20 PlS Planned sale Sarret Joseph J.

Chief Business Officer

Officer
2,038 -21.5%
8.95
US$18,232 		2,038 -21.5% 8.95 US$18,232
2017-07-05 2017-06-30 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
301,004 +5.4%
7.71
US$2,319,236 		301,004 +5.4% 7.71 US$2,319,236
2017-05-25 2017-05-25 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
1,902,400 +52.2%
6.25
US$11,890,000 		1,902,400 +52.2% 6.25 US$11,890,000
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
6,341 +112.1%
3.70
US$23,453 		6,341 +112.1% 3.70 US$23,453
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
7,790 +165.4%
3.71
US$28,879 		7,790 +165.4% 3.71 US$28,879
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
5,659 +inf%
3.57
US$20,179 		5,659 +inf% 3.57 US$20,179
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
4,710 +inf%
3.54
US$16,688 		4,710 +inf% 3.54 US$16,688
2016-05-17 2016-05-16 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,500 +22.9%
3.70
US$24,046 		6,500 +22.9% 3.70 US$24,046
2016-05-17 2016-05-13 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,000 +26.8%
3.50
US$20,996 		6,000 +26.8% 3.50 US$20,996
2016-05-16 2016-05-12 B Purchase GREENWOOD DAVID Non-Executive Director
3,000 +inf%
3.58
US$10,742 		3,000 +inf% 3.58 US$10,742
2015-02-26 2015-02-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
3,600 +19.2%
6.99
US$25,169 		3,600 +19.2% 6.99 US$25,169
2014-11-24 2014-11-24 B Purchase BREUIL ROBERT S

Chief Financial Officer

Officer
1,600 +40.0%
5.40
US$8,640 		1,600 +40.0% 5.40 US$8,640
2014-11-24 2014-11-21 B Purchase STAPLE PETER D

President & CEO

Executive Director
9,000 +92.0%
5.34
US$48,055 		9,000 +92.0% 5.34 US$48,055
2014-08-27 2014-08-27 B Purchase STAPLE PETER D

President & CEO

Executive Director
300 +3.2%
6.20
US$1,860 		300 +3.2% 6.20 US$1,860
2014-08-27 2014-08-26 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,000 +11.8%
6.14
US$6,144 		1,000 +11.8% 6.14 US$6,144
2014-08-27 2014-08-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,278 +17.8%
6.05
US$7,726 		1,278 +17.8% 6.05 US$7,726
2014-05-30 2014-05-30 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,400 +50.0%
7.08
US$16,982 		2,400 +50.0% 7.08 US$16,982
2014-05-30 2014-05-29 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,900 +152.6%
7.08
US$20,518 		2,900 +152.6% 7.08 US$20,518
2014-05-30 2014-05-28 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,900 +inf%
6.95
US$13,206 		1,900 +inf% 6.95 US$13,206
2014-04-08 2014-04-08 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
2014-04-08 2014-04-08 B Purchase Eastman Ronald W Non-Executive Director Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
Explore more

More insider trading research around Corium International Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America